Profil
Ms. Grith Hagel is a Director & Vice President-Innovation at 2cureX AB and a Head-Project Management at 2cureX ApS.
She is on the Board of Directors at 2cureX AB. Ms. Hagel was previously employed as a Principal by Carlsberg A/S, a Co-Founder by Noapab Holdings A/S, and a Principal by Novo Nordisk A/S.
Postes actifs de Grith Hagel
| Sociétés | Poste | Début |
|---|---|---|
| 2CUREX AB | Fondateur | 01/01/2006 |
2cureX ApS
2cureX ApS Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs and technology for the treatment of cancer | Fondateur | 07/04/2010 |
Anciens postes connus de Grith Hagel
| Sociétés | Poste | Fin |
|---|---|---|
| CARLSBERG A/S | Corporate Officer/Principal | - |
Noapab Holdings A/S
Noapab Holdings A/S Miscellaneous Commercial ServicesCommercial Services Develops pharmaceuticals and diagnostics products | Fondateur | - |
| NOVO NORDISK A/S | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Novo Nordisk A/S
Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
Carlsberg A/S
Carlsberg A/S Beverages: AlcoholicConsumer Non-Durables Produces and markets beers and soft drinks | Consumer Non-Durables |
Noapab Holdings A/S
Noapab Holdings A/S Miscellaneous Commercial ServicesCommercial Services Develops pharmaceuticals and diagnostics products | Commercial Services |
2cureX ApS
2cureX ApS Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs and technology for the treatment of cancer | Health Technology |
2cureX AB
2cureX AB Medical SpecialtiesHealth Technology Develops and supplies in vitro diagnostic (IVD) devices | Health Technology |
















